Cargando…

PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice

Neutrophils are important components in the innate immune system. Neutrophil hyperactivation is regarded as a characteristic of Alzheimer's disease (AD). But in vivo imaging tools observing neutrophil activity in AD dynamically is lacking. This study aimed to identify neutrophil infiltration in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Yanyan, Liu, Kawai, Hua, Tao, Zhang, Chencheng, Sun, Bomin, Guan, Yihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758535/ https://www.ncbi.nlm.nih.gov/pubmed/33362678 http://dx.doi.org/10.3389/fneur.2020.523798

Ejemplares similares

Progress of RAGE Molecular Imaging in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2020)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of (18)F/(123)I‐FP‐CIT studies
por: Kong, Yanyan, et al.
Publicado: (2020)

Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
por: Meier, Silvio R., et al.
Publicado: (2018)

PET Imaging of Neuroinflammation in Alzheimer’s Disease
por: Zhou, Rong, et al.
Publicado: (2021)

Positron Emission Computed Tomography Imaging of Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2021)

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
por: Kong, Yanyan, et al.
Publicado: (2020)

Imaging Insights of Isolated Idiopathic Dystonia: Voxel-Based Morphometry and Activation Likelihood Estimation Studies
por: Wu, Yunhao, et al.
Publicado: (2022)

Variable High-Frequency Deep Brain Stimulation of the Subthalamic Nucleus for Speech Disorders in Parkinson's Disease: A Case Report
por: Zhang, Chencheng, et al.
Publicado: (2019)

Elucidating the Relationship Between Diabetes Mellitus and Parkinson’s Disease Using (18)F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2
por: Kong, Yanyan, et al.
Publicado: (2020)

Fixed-Life or Rechargeable Battery for Deep Brain Stimulation: Preference and Satisfaction in Chinese Patients With Parkinson's Disease
por: Qiu, Xian, et al.
Publicado: (2021)

Corrigendum: Fixed-life or rechargeable battery for deep brain stimulation: preference and satisfaction in Chinese patients with Parkinson's disease
por: Qiu, Xian, et al.
Publicado: (2023)

Fixed-Life or Rechargeable Batteries for Deep Brain Stimulation: Preference and Satisfaction Among Patients With Hyperkinetic Movement Disorders
por: Qiu, Xian, et al.
Publicado: (2021)

The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment
por: Kong, Yanyan, et al.
Publicado: (2021)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
por: Gouilly, Dominique, et al.
Publicado: (2023)

Effects of Unilateral Stimulation in Parkinson's Disease: A Randomized Double-Blind Crossover Trial
por: Zeng, Zhitong, et al.
Publicado: (2022)

Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis
por: Zhang, Junjiao, et al.
Publicado: (2023)

Awake (18)F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice
por: Miranda, Alan, et al.
Publicado: (2019)

Quantitative (18)F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
por: Zhao, Qian, et al.
Publicado: (2019)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Noninvasive Relative Quantification of [(11)C]ABP688 PET Imaging in Mice Versus an Input Function Measured Over an Arteriovenous Shunt
por: Verhaeghe, Jeroen, et al.
Publicado: (2018)

In vivo Imaging of Glial Activation in Alzheimer's Disease
por: Edison, Paul, et al.
Publicado: (2018)

Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice
por: Xin, Yang, et al.
Publicado: (2018)

Identification of genetic molecular markers and immune infiltration characteristics of Alzheimer's disease through weighted gene co-expression network analysis
por: Duan, KeFei, et al.
Publicado: (2022)

Quantitative Evaluation of (18)F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
por: Matsuda, Hiroshi, et al.
Publicado: (2021)

Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET
por: Momota, Yuki, et al.
Publicado: (2022)

Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein
por: Peters, Samuel T., et al.
Publicado: (2020)

Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome
por: Martin, Lee J., et al.
Publicado: (2020)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Characteristics and influencing factors of (11)C-CFT PET imaging in patients with early and late onset Parkinson’s disease
por: Kangli, Fan, et al.
Publicado: (2023)

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
por: Bao, Weiqi, et al.
Publicado: (2021)

Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation
por: Tateyama, Maki, et al.
Publicado: (2015)

Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing
por: Johnson, Jason Michael, et al.
Publicado: (2021)

Tau PET With (18)F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation
por: Huang, Chin-Chang, et al.
Publicado: (2019)

Corrigendum: Characteristics and influencing factors of (11)C-CFT PET imaging in patients with early and late onset Parkinson's disease
por: Kangli, Fan, et al.
Publicado: (2023)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

Astrocyte HIV-1 Tat Differentially Modulates Behavior and Brain MMP/TIMP Balance During Short and Prolonged Induction in Transgenic Mice
por: Joshi, Chaitanya R., et al.
Publicado: (2020)

White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes
por: Zhou, Jinyu, et al.
Publicado: (2022)

Admission neutrophil-to-lymphocyte ratio to predict 30-day mortality in severe spontaneous basal ganglia hemorrhage
por: Shi, Jia, et al.
Publicado: (2023)

Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging
por: Traub-Weidinger, Tatjana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_roepeeml0m00r5n4leptpbbhkk